EAM Global Investors’s Mirum Pharmaceuticals MIRM Stock Holding History

EAM Global Investors’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-61,233	Closed	-$1.19M	–	215
2022 Q2	$1.19M	Sell	61,233 -18,503	-23%	-$436K	0.29%	167
2022 Q1	$1.76M	Buy	+79,736	New	+$1.63M	0.32%	165
2020 Q2	–	Sell	-69,237	Closed	-$969K	–	137
2020 Q1	$969K	Buy	69,237 +8,728	+14%	+$143K	0.57%	87
2019 Q4	$1.48M	Buy	+60,509	New	+$645K	0.59%	96

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

EAM Global Investors's MIRM Position: Q3 2022 in Review

EAM Global Investors sold out of Mirum Pharmaceuticals (MIRM) in Q3 2022, closing a stake of 61,233 shares — an estimated $1.19M sold.

EAM Global Investors first reported a position in MIRM in Q4 2019 and held it in 4 quarters. The position peaked at $1.76M in Q1 2022. 112 funds tracked by Wall St. Rank hold MIRM as of Q3 2022.

EAM Global Investors reported no remaining Mirum Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
EAM Global Investors sold 61,233 Mirum Pharmaceuticals shares in Q3 2022, an estimated $1.19M.
EAM Global Investors first reported a position in Mirum Pharmaceuticals in Q4 2019 and held it in 4 quarters.
EAM Global Investors's Mirum Pharmaceuticals position peaked at $1.76M in Q1 2022.
112 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2022.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.